ツムラの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/01/21 | 3,160 | 3,165 | 3,130 | 3,135 | -45 | -1.4% | 115,600 |
2020/01/20 | 3,195 | 3,200 | 3,175 | 3,180 | -30 | -0.9% | 101,300 |
2020/01/17 | 3,245 | 3,250 | 3,200 | 3,210 | ±0 | ±0% | 132,200 |
2020/01/16 | 3,270 | 3,270 | 3,205 | 3,210 | ±0 | ±0% | 132,000 |
2020/01/15 | 3,205 | 3,240 | 3,200 | 3,210 | +35 | +1.1% | 195,900 |
2020/01/14 | 3,200 | 3,205 | 3,155 | 3,175 | -15 | -0.5% | 203,700 |
2020/01/10 | 3,185 | 3,210 | 3,180 | 3,190 | +30 | +0.9% | 128,400 |
2020/01/09 | 3,170 | 3,180 | 3,155 | 3,160 | +30 | +1% | 86,100 |
2020/01/08 | 3,140 | 3,150 | 3,070 | 3,130 | -70 | -2.2% | 199,500 |
2020/01/07 | 3,160 | 3,210 | 3,140 | 3,200 | +65 | +2.1% | 201,600 |
2020/01/06 | 3,140 | 3,150 | 3,115 | 3,135 | -75 | -2.3% | 225,800 |
2019/12/30 | 3,245 | 3,260 | 3,210 | 3,210 | -40 | -1.2% | 105,700 |
2019/12/27 | 3,255 | 3,265 | 3,245 | 3,250 | +5 | +0.2% | 97,200 |
2019/12/26 | 3,235 | 3,260 | 3,225 | 3,245 | +10 | +0.3% | 100,700 |
2019/12/25 | 3,255 | 3,255 | 3,230 | 3,235 | -5 | -0.2% | 83,500 |
2019/12/24 | 3,240 | 3,255 | 3,230 | 3,240 | +5 | +0.2% | 87,300 |
2019/12/23 | 3,260 | 3,260 | 3,230 | 3,235 | +5 | +0.2% | 85,300 |
2019/12/20 | 3,250 | 3,260 | 3,205 | 3,230 | -5 | -0.2% | 138,900 |
2019/12/19 | 3,220 | 3,250 | 3,205 | 3,235 | +10 | +0.3% | 128,700 |
2019/12/18 | 3,250 | 3,250 | 3,215 | 3,225 | -20 | -0.6% | 120,500 |
2019/12/17 | 3,220 | 3,255 | 3,200 | 3,245 | +55 | +1.7% | 152,400 |
2019/12/16 | 3,195 | 3,210 | 3,170 | 3,190 | +15 | +0.5% | 127,100 |
2019/12/13 | 3,245 | 3,255 | 3,160 | 3,175 | -5 | -0.2% | 252,700 |
2019/12/12 | 3,225 | 3,225 | 3,180 | 3,180 | -30 | -0.9% | 116,900 |
2019/12/11 | 3,245 | 3,250 | 3,195 | 3,210 | -20 | -0.6% | 180,800 |
2019/12/10 | 3,235 | 3,245 | 3,220 | 3,230 | +10 | +0.3% | 135,500 |
2019/12/09 | 3,225 | 3,240 | 3,200 | 3,220 | +30 | +0.9% | 101,700 |
2019/12/06 | 3,210 | 3,210 | 3,180 | 3,190 | -15 | -0.5% | 108,000 |
2019/12/05 | 3,195 | 3,230 | 3,190 | 3,205 | +20 | +0.6% | 163,000 |
2019/12/04 | 3,130 | 3,185 | 3,120 | 3,185 | +25 | +0.8% | 148,300 |
2019/12/03 | 3,160 | 3,165 | 3,135 | 3,160 | -35 | -1.1% | 160,700 |
2019/12/02 | 3,240 | 3,240 | 3,190 | 3,195 | -70 | -2.1% | 170,500 |
2019/11/29 | 3,290 | 3,300 | 3,255 | 3,265 | ±0 | ±0% | 118,500 |
2019/11/28 | 3,300 | 3,300 | 3,255 | 3,265 | +15 | +0.5% | 99,800 |
2019/11/27 | 3,255 | 3,275 | 3,250 | 3,250 | -5 | -0.2% | 87,700 |
2019/11/26 | 3,300 | 3,310 | 3,245 | 3,255 | -15 | -0.5% | 183,200 |
2019/11/25 | 3,285 | 3,290 | 3,245 | 3,270 | +20 | +0.6% | 120,100 |
2019/11/22 | 3,245 | 3,255 | 3,215 | 3,250 | +45 | +1.4% | 164,900 |
2019/11/21 | 3,245 | 3,245 | 3,160 | 3,205 | -45 | -1.4% | 131,200 |
2019/11/20 | 3,240 | 3,255 | 3,200 | 3,250 | +65 | +2% | 196,200 |
2019/11/19 | 3,175 | 3,220 | 3,170 | 3,185 | +10 | +0.3% | 194,800 |
2019/11/18 | 3,150 | 3,180 | 3,120 | 3,175 | +35 | +1.1% | 161,000 |
2019/11/15 | 3,110 | 3,160 | 3,110 | 3,140 | +40 | +1.3% | 125,100 |
2019/11/14 | 3,115 | 3,135 | 3,095 | 3,100 | -25 | -0.8% | 126,000 |
2019/11/13 | 3,180 | 3,180 | 3,110 | 3,125 | -70 | -2.2% | 204,000 |
2019/11/12 | 3,215 | 3,245 | 3,190 | 3,195 | -25 | -0.8% | 188,000 |
2019/11/11 | 3,290 | 3,295 | 3,215 | 3,220 | -10 | -0.3% | 131,800 |
2019/11/08 | 3,235 | 3,260 | 3,205 | 3,230 | +20 | +0.6% | 254,900 |
2019/11/07 | 3,120 | 3,295 | 3,100 | 3,210 | +185 | +6.1% | 594,300 |
2019/11/06 | 3,045 | 3,045 | 3,000 | 3,025 | -35 | -1.1% | 194,900 |
1351~
1400
件表示中 / 3750件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ツムラ | 365,900円 | +3.8% | -19.9% | 3.72% | 11.88倍 | 0.91倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
住友ファーマ | 113,700円 | -11.0% | +206.6% | 0.00% | 11.29倍 | 2.67倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
久光薬 | 399,300円 | +5.8% | +1.2% | 3.01% | 12.93倍 | 1.03倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
日本新薬 | 318,900円 | +8.0% | -15.3% | 3.89% | 8.95倍 | 0.87倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
サワイGHD | 193,400円 | +5.9% | +684.6% | 2.84% | 12.84倍 | 1.28倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
市場注目の銘柄
チャート関連のコラム